Richard W. Bond

Person

Union, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Patent number 7,964,646
- Issue date Jun 21, 2011
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Patent number 7,947,720
- Issue date May 24, 2011
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Patent number 7,132,445
- Issue date Nov 7, 2006
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating androgen-dependent disorders
- Patent number 6,710,037
- Issue date Mar 23, 2004
- Schering Corporation
- Lynn Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor...
- Publication number 20110213029
- Publication date Sep 1, 2011
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR...
- Publication number 20090306079
- Publication date Dec 10, 2009
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20070021494
- Publication date Jan 25, 2007
- Schering Corporation and Pharmacopeia, Inc.
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20040235908
- Publication date Nov 25, 2004
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20040147559
- Publication date Jul 29, 2004
- Schering Corporation and Pharmacopeia, Inc.
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20040106794
- Publication date Jun 3, 2004
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...
- Publication number 20040097547
- Publication date May 20, 2004
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine recepto...
- Publication number 20030204085
- Publication date Oct 30, 2003
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor...
- Publication number 20030097004
- Publication date May 22, 2003
- Schering Corporation
- Arthur G. Taveras
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method of treating androgen-dependent disorders
- Publication number 20020165195
- Publication date Nov 7, 2002
- Schering Corporation
- Lynn Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Richard W. Bond

Person

Patents Grantslast 30 patents

3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

Method of treating androgen-dependent disorders

Patents Applicationslast 30 patents

3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor...

3,4-DI-SUBSTITUTED CYCLOBUTENE-1,2-DIONES AS CXC-CHEMOKINE RECEPTOR...

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor...

3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine recepto...

3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor...

Method of treating androgen-dependent disorders